RX EVERYONE EVERYWHERE
DEAD

Serial Number

88749016

Owner

RXE2 LLC

Attorney

Joshua G. Gigger

Filing Date

Jan 7, 2020

Add to watchlist:

No watchlists yet
View on USPTO

RX EVERYONE EVERYWHERE Trademark

Serial Number: 88749016

RX EVERYONE EVERYWHERE is a trademark filed by RXE2 LLC on January 7, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

RXE2 LLC (7 trademarks)

FARGO, ND 58103

Entity Type: 16

Trademark Details

Filing Date

January 7, 2020

Registration Date

Not Registered

Published for Opposition

July 4, 2023

Goods & Services

Pharmacy benefit management services

Downloadable software in the nature of a mobile application for use in providing information relating to electronic health records and clinical trials

Pharmacy packaging services, namely, packaging, labeling, aligning and sorting medication by date and time into individual packages and containers for patients and healthcare professionals; delivery of goods for others, namely, delivery of medication, device and clinical supply packages and containers by date and time and category for patients and healthcare providers

Pharmaceutical and pharmacy services, namely, processing and dispensing online and telephone prescription orders for online clinical and retail pharmacies; maintaining a registry of national and international databases in the field of pharmaceuticals, medical devices, clinical trials, and healthcare; maintaining databases of pharmacies, pharmacists, and other healthcare professionals who can assist with the delivery of pharmaceutical services; retail pharmacy services; online retail pharmacy services; mail order pharmacy services; promoting the exchange of information and resources within the pharmaceutical, medical device, clinical trial, and medical communities to achieve advances in the fields of clinical research and healthcare; providing a website featuring statistical data and feedback on healthcare provider's performance for the purpose of assisting prospective patients in making physician, pharmacist, and other healthcare professional selection decisions; recruitment advertisement services, namely, posting of clinical trial notices for the purposes of providing clinical trial status, and recruiting and informing patients for participation in clinical trials for the testing of drugs and medical devices; providing needed information on the topics of healthcare operations management for promoting patient satisfaction via a global computer network; global patient relationship management services; and global consulting services in the field of patient relationship management for healthcare providers

Dispensing of medications by date and time and category for patients and healthcare providers; population health services, namely, gathering of global patient healthcare and behavioral data for the benefit of improving healthcare for individual patients, groups of patients, and populations; pharmaceutical advice; preparation of prescriptions in pharmacies; dispensing of pharmaceuticals; providing healthcare information; medical and pharmaceutical consultation; medical and pharmaceutical counseling via online or remote communication means; medical drug monitoring and alert service for healthcare providers and patients, namely, providing medication therapy management, medicinal dosage, allergic sensitivity, and prescription safety information for medical treatment purposes; telemedicine services; telepharmacy services, namely, providing medical and pharmaceutical consultation and advice via online or remote communication means; providing information to patients in the field of administering, use and storage of medications; and providing medical information to patients in the form of reports in the field of pharmaceuticals and medical devices

Pharmaceutical and medical device services, namely, providing pharmacist medical and scientific research counseling services to patients and healthcare providers as well as patients and healthcare providers participating in clinical trials for pharmaceutical, biotechnology, and medical device development and testing; providing a website featuring online non-downloadable software applications used for providing information about healthcare, and investigational medical devices, diagnostics and pharmaceuticals; providing online, non-downloadable software for use in providing information relating to electronic health records; medical and scientific research information in the field of healthcare; conducting clinical trials for others

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 1, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 1, 2024 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 29, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 4, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 4, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 14, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 31, 2023 CNSA
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 1, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 31, 2022 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 30, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 30, 2021 GNSL
SUSPENSION LETTER WRITTEN
Nov 30, 2021 CNSL
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 29, 2021 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 22, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 22, 2020 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 22, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 22, 2020 GNSL
SUSPENSION LETTER WRITTEN
Apr 22, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 31, 2020 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 31, 2020 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 31, 2020 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Mar 31, 2020 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Mar 31, 2020 CPEA
ASSIGNED TO EXAMINER
Mar 26, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2020 NWOS
NEW APPLICATION ENTERED
Jan 10, 2020 NWAP